Javascript must be enabled to continue!
Cleavage, down-regulation and aggregation of serum amyloid A
View through CrossRef
Abstract
Various diseases cause over-expression of the serum amyloid A protein (SAA), which leads in some, but not all, cases to amyloidosis as a secondary disease. The response to the over-expression involves dissociation of SAA hexamer and subsequent cleavage of the released monomers, most commonly yielding fragments SAA
1−76
of the full-sized SAA
1−104
. We report results from molecular dynamic simulations that probe the role of this cleavage for down-regulating activity and the concentration of SAA. We propose a mechanism that relies on two elements. First, the probability to assemble into hexamers is lower for the fragments than it is for the full-sized protein. Second, unlike other fragments SAA
1−76
can switch between two distinct configurations. The first kind is easy to proteolyze (allowing a fast reduction of SAA concentration) but prone to aggregation, while the situation is opposite for the second kind. If the time scale for amyloid formation is longer than the one for proteolysis, the aggregation-prone species dominates. However, if environmental conditions such as low pH increase the risk of amyloid formation, the ensemble shifts toward the more protected form. We speculate that SAA amyloidosis is a failure of the switching mechanism leading to accumulation of the aggregation-prone species and subsequent amyloid formation.
Title: Cleavage, down-regulation and aggregation of serum amyloid A
Description:
Abstract
Various diseases cause over-expression of the serum amyloid A protein (SAA), which leads in some, but not all, cases to amyloidosis as a secondary disease.
The response to the over-expression involves dissociation of SAA hexamer and subsequent cleavage of the released monomers, most commonly yielding fragments SAA
1−76
of the full-sized SAA
1−104
.
We report results from molecular dynamic simulations that probe the role of this cleavage for down-regulating activity and the concentration of SAA.
We propose a mechanism that relies on two elements.
First, the probability to assemble into hexamers is lower for the fragments than it is for the full-sized protein.
Second, unlike other fragments SAA
1−76
can switch between two distinct configurations.
The first kind is easy to proteolyze (allowing a fast reduction of SAA concentration) but prone to aggregation, while the situation is opposite for the second kind.
If the time scale for amyloid formation is longer than the one for proteolysis, the aggregation-prone species dominates.
However, if environmental conditions such as low pH increase the risk of amyloid formation, the ensemble shifts toward the more protected form.
We speculate that SAA amyloidosis is a failure of the switching mechanism leading to accumulation of the aggregation-prone species and subsequent amyloid formation.
Related Results
Reasons for undergoing amyloid imaging among cognitively unimpaired older adults
Reasons for undergoing amyloid imaging among cognitively unimpaired older adults
AbstractObjectivesPreclinical Alzheimer’s disease (AD) clinical trials screen cognitively unimpaired older adults for biomarker criteria and disclose their results. We examined whe...
Protein aggregation, hydrophobicity and neurodegenerative disease
Protein aggregation, hydrophobicity and neurodegenerative disease
In this thesis, we study the relationship between proteins and neurodegenerative disease using different computational and experimental approaches. We focus on two disease mechanis...
Pathological and neurophysiological outcomes of seeding human-derived tau pathology in the APP-KI NL-G-F and NL-NL mouse models of Alzheimer’s Disease
Pathological and neurophysiological outcomes of seeding human-derived tau pathology in the APP-KI NL-G-F and NL-NL mouse models of Alzheimer’s Disease
AbstractThe two main histopathological hallmarks that characterize Alzheimer’s Disease are the presence of amyloid plaques and neurofibrillary tangles. One of the current approache...
Differential WMH progression trajectories in progressive and stable mild cognitive impairment
Differential WMH progression trajectories in progressive and stable mild cognitive impairment
AbstractBackgroundPathological brain changes such as white matter hyperintensities (WMHs) occur with increased age and contribute to cognitive decline. Current research is still un...
A glycan biomarker predicts cognitive decline in amyloid- and tau-negative patients
A glycan biomarker predicts cognitive decline in amyloid- and tau-negative patients
Abstract
Early detection of Alzheimer’s disease is vital for timely treatment. Existing biomarkers for Alzheimer’s disease reflect amyloid- and tau-related pathology...
Relationship between comprehensive geriatric assessment and amyloid PET in older persons with MCI
Relationship between comprehensive geriatric assessment and amyloid PET in older persons with MCI
Abstract
Background. The association between amyloid deposition and cognitive, behavioral and physical performance in mild cognitive impairment (MCI) due to Alzheimer's dis...
Diagnostic Accuracy of Serum and Urine S100A8/A9 and Serum Amyloid A in Probable Acute Abdominal Pain at Emergency Department
Diagnostic Accuracy of Serum and Urine S100A8/A9 and Serum Amyloid A in Probable Acute Abdominal Pain at Emergency Department
Study Design. This study was performed to investigate the diagnostic values of some inflammatory biomarkers in abdominal pain. Methods. Patients over 18 years of age with acute rec...
How to find simple and accurate rules for viral protease cleavage specificities
How to find simple and accurate rules for viral protease cleavage specificities
BACKGROUND:Proteases of human pathogens are becoming increasingly important drug targets, hence it is necessary to understand their substrate specificity and to interpret this know...

